Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary extracted from

  • Han, Y.; Liu, Y.; Fu, X.; Zhang, Q.; Huang, H.; Zhang, C.; Li, W.; Zhang, J.
    miR-9 inhibits the metastatic ability of hepatocellular carcinoma via targeting beta galactoside alpha-2,6-sialyltransferase 1 (2018), J. Physiol. Biochem., 74, 491-501 .
    View publication on PubMed

Natural Substrates/ Products (Substrates)

EC Number Natural Substrates Organism Comment (Nat. Sub.) Natural Products Comment (Nat. Pro.) Rev. Reac.
2.4.3.1 CMP-N-acetyl-beta-neuraminate + beta-D-galactosyl-R Mus musculus
-
CMP + N-acetyl-alpha-neuraminyl-(2->6)-beta-D-galactosyl-R
-
?

Organism

EC Number Organism UniProt Comment Textmining
2.4.3.1 Mus musculus Q64685
-
-

Source Tissue

EC Number Source Tissue Comment Organism Textmining
2.4.3.1 Hca-F cell
-
Mus musculus
-
2.4.3.1 Hca-P cell
-
Mus musculus
-
2.4.3.1 HEPA 1-6 cell
-
Mus musculus
-
2.4.3.1 hepatoma cell
-
Mus musculus
-

Substrates and Products (Substrate)

EC Number Substrates Comment Substrates Organism Products Comment (Products) Rev. Reac.
2.4.3.1 CMP-N-acetyl-beta-neuraminate + beta-D-galactosyl-R
-
Mus musculus CMP + N-acetyl-alpha-neuraminyl-(2->6)-beta-D-galactosyl-R
-
?

Synonyms

EC Number Synonyms Comment Organism
2.4.3.1 beta galactoside alpha-2,6-sialyltransferase 1
-
Mus musculus
2.4.3.1 ST6Gal1
-
Mus musculus

Expression

EC Number Organism Comment Expression
2.4.3.1 Mus musculus the enzyme expression level is associated negatively with microRNA miR-9 down